GC Cell Corporation
KOE: 144510.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jai-Wang Kim
- Employees
- 752
- Headquarters
- Yongin-Si, South Korea
- IPO year
- 2016
- Market cap
- ₩335.9B
- Website
- https://www.gccell.com
Loading 144510…
Loading profile data…Frequently asked questions about 144510
What does GC Cell Corporation (144510.KQ) do?
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin, South Ko...
Where does 144510.KQ trade?
GC Cell Corporation (144510.KQ) trades on the KOSDAQ.
What sector is 144510.KQ in?
GC Cell Corporation (144510.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GC Cell Corporation?
Jai-Wang Kim is the chief executive officer of GC Cell Corporation (144510.KQ).
Where is GC Cell Corporation headquartered?
GC Cell Corporation is headquartered in South Korea.
Does 144510.KQ pay a dividend?
Yes — GC Cell Corporation (144510.KQ) paid a trailing twelve-month dividend of KRW 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 144510.KQ go public?
GC Cell Corporation (144510.KQ) completed its initial public offering in 2016.